Efficacy and safety of anticancer drug combinations: a meta-analysis of randomized trials with a focus on immunotherapeutics and gene-targeted compounds

Hundreds of trials are being conducted to evaluate combination of newer targeted drugs as well as immunotherapy. Our aim was to compare efficacy and safety of combination versus single non-cytotoxic anticancer agents. We searched PubMed (01/01/2001 to 03/06/2018) (and, for immunotherapy, ASCO and ES...

Descripción completa

Detalles Bibliográficos
Autores principales: Jardim, Denis L., De Melo Gagliato, Débora, Nikanjam, Mina, Barkauskas, Donald A., Kurzrock, Razelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6959453/
https://www.ncbi.nlm.nih.gov/pubmed/32002305
http://dx.doi.org/10.1080/2162402X.2019.1710052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6959453/
https://www.ncbi.nlm.nih.gov/pubmed/32002305
http://dx.doi.org/10.1080/2162402X.2019.1710052

Ejemplares similares